Treatment of epidermolysis bullosa pruriginosa‐associated pruritus with dupilumab-Reference-Cited by-同舟云学术

Treatment of epidermolysis bullosa pruriginosa‐associated pruritus with dupilumab

Published:2020-01-29 Issue:6 Volume:182 Page:1495-1497
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Shehadeh W.¹,Sarig O.¹,Bar J.¹,Sprecher E.¹²,Samuelov L.¹^ORCID

Affiliation:

1. Department of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18855

Reference8 articles.

1. Allelic Heterogeneity of Dominant and Recessive COL7A1 Mutations Underlying Epidermolysis Bullosa Pruriginosa

2. Dupilumab shows long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis enrolled in a phase 3 open‐label extension study;Deleuran M;J Am Acad Dermatol,2019

3. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis

4. Dominant dystrophic epidermolysis bullosa pruriginosa responding to naltrexone treatment;Pallesen KAU;Acta Derm Venereol,2019

5. Dystrophic epidermolysis bullosa pruriginosa successfully treated with immunosuppressants

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa;Skin Health and Disease;2024-08-19

2. Treatment of Epidermolysis Bullosa and Future Directions: A Review;Dermatology and Therapy;2024-08

3. Unveiling the value of C‐reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross‐sectional study;Experimental Dermatology;2024-07-29

4. Systematic review on antipruritic therapies for patients with Epidermolysis bullosa;Journal of Dermatological Treatment;2024-07-28

5. Unmet needs in treating itch: reaching beyond eczema;Journal of Dermatological Treatment;2024-06-13